SIERRA WILLIAMS-BARNHART: Open Payments
NPI 1114589371 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 31 payments from 15 companies in 2025. Trend: 2023 $540 · 2024 $886 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $128 |
| AstraZeneca Pharmaceuticals LP | 4 | $101 |
| Janssen Biotech, Inc. | 5 | $101 |
| GlaxoSmithKline, LLC. | 1 | $86 |
| Daiichi Sankyo Inc. | 3 | $70 |
| Lilly USA, LLC | 2 | $64 |
| BeOne Medicines USA, Inc. | 2 | $46 |
| Incyte Corporation | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Deciphera Pharmaceuticals Inc. | 1 | $24 |
Products named: ICLUSIG, Enhertu, VERZENIO, IMFINZI, BRUKINSA, JAKAFI, RYBREVANT, FRUZAQLA.
Industry payments across FL — which companies pay providers there.
